M.D. Articles
-
Microbot Medical Enhances its Scientific Advisory Board (SAB) with its Newest Member Dr. Vincent Vidal
Prominent France based interventional radiologist to leverage his expertise to assist the Company to achieve its future objective for the LIBERTY® Robotic System HINGHAM, Mass., Sept. 15, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), which continues to build a network of global leaders in the endovascular interventional space for the LIBERTY® Robotic System, today ...
-
DR Systems and Vidar Partner to Ease the Transition to Digital Mammography - Case Study
DR Systems. Inc.. is a leading provider of integrated medical image management systems for hospitals and imaging centers. Co-founded in 1992 by practicing radiologist Murray Reicher, M.D.. the company has become one of the preeminent vendors in the PACS industry and serves facilities of all sizes, ranging from one of the smallest hospitals in the United States to large academic medical centers ...
-
World’s First aprevo Personalized Spine Surgery Performed Using the Only Available Spine Technology with FDA Breakthrough Designation
SAN DIEGO--(BUSINESS WIRE)--Carlsmed, Inc. is announcing today that the firstaprevopatient specific spinal surgery has been successfully performed. Christopher Ames, M.D., director of spinal tumor and spinal deformity surgery at UC San Francisco Medical Center, assisted by Patrick Maloney, M.D., performed this landmark surgical procedure. “Carlsmed’s aprevofamily of devices represent ...
-
Pioneering VeraForm in Head and Neck Cancer Treatment: Sarcomatoid Carcinoma Tumor Bed Marking
Head and neck cancer surgery presents a number of unique challenges, not only for the surgeon but for the radiation oncologist who will subsequently treat those patients. Great care with an emphasis on precision must be taken to ensure that critical structures and tissues avoid collateral damage when possible. However, given the surgical site often lies in soft tissue, exact identification of the ...
-
Regenstrief, IU study finds assigning hospitalists by unit has both pros and cons
Researchers from Regenstrief Institute and Indiana University School of Medicine have conducted the first time-motion study in more than a decade to assess the impact of geographic cohorting of hospitalists. Geographic cohorting –- restricting or localizing hospitalists and their patients to one or two inpatient units rather than having hospitalists travel from floor to floor, across wings ...
-
Amplifi Vein Dilation System: A novel device under development designed to prepare veins for AVF creation
The Amplifi Vein Dilation System (Artio Medical) is is an innovative device designed to dilate arm veins in preparation for AVF surgery using rapid, non-pulsatile venous blood flow. Surendra Shenoy, M.D. (a vascular surgeon with specialist interest in vascular access and transplantation at Washington University School of Medicine, St Louis, Missouri, USA) describes the system as one of the most ...
-
Global Partnership to Improve Diagnostic Accuracy of Breast Cancer
Femtech World featured our partnership with PathPresenter to distribute the 4D Q-plasia OncoReader Breast within PathPresenter’s ClinPx Clinical Workflow Platform in their magazine. The primary purpose of integrating 4D Path’s proprietary algorithms within the PathPresenter ClinPx platform is to potentially improve the throughput, reliability, and quality of consultations ...
By 4D Path Inc.
-
FluGen Announces Completion of First Cohort in Age De-escalation Clinical Trial of M2SR Flu Vaccine Candidate in Pediatric Subjects Ages 6 Months to 17 Years
MADISON, Wis., Sept. 7, 2022 /PRNewswire/ — FluGen, Inc., a clinical-stage vaccine company transforming vaccine efficacy in infectious respiratory diseases, today announced the completion of enrollment of the first cohort in an age de-escalation clinical trial of M2SR (M2 Deficient Single Replication) live virus vaccine, the company’s investigational supra-seasonal intranasal ...
By FluGen, Inc.
-
Endoscope and Light Source that was donated from Medit Inc. for Doctors in Ethiopia
Medit Inc, one of the leaders among online suppliers of endoscopic equipment and accessories in North America, is pleased to announce great feedback that arrived from doctors in Ethiopia who have recently received a new endoscope and a light source as a donation from the company. At the beginning of 2014 the company was contacted by Jerald S. Altman, M.D. from Valley ENT with the request to ...
-
A Conversation with Prof. Davide Capodanno, M.D., Ph.D. on the Landmark TAILOR-PCI Clinical Trial Results
After seven years and 5,300-patients tested, the results of the landmark TAILOR-PCI trial were announced in a virtual ACC session. This trial investigated whether a prospective approach using rapid on-site CYP2C19 testing could improve patient outcomes when selecting P2Y12 inhibitor therapy following PCI procedure. This is based on the well-established evidence that approximately 30-50% of ...
By Genomadix
-
Novel technology targets melasma
Could this new drug delivery system for tranexamic acid optimize melasma treatment? Joel Cohen, M.D., thinks it could be just what the specialty has been looking for. Researchers using a novel transdermal drug delivery system to deliver tranexamic acid deep into melasma patients’ skin found the technology-assisted treatment quickly and notably reduced the skin pigmentation of ...
-
Endoscope and Light Source that was donated from Medit Inc. for Doctors in Ethiopia
Medit Inc, one of the leaders among online suppliers of endoscopic equipment and accessories in North America, is pleased to announce great feedback that arrived from doctors in Ethiopia who have recently received a new endoscope and a light source as a donation from the company. At the beginning of 2014 the company was contacted by Jerald S. Altman, M.D. from Valley ENT with the request to ...
-
Rational Vaccines Announces a Clinical Trial to Determine Baseline Characteristics of Patients Diagnosed With Recurrent Symptomatic Herpes Simplex Type 2 (HSV-2) Virus
Study to be conducted at two leading research institutions in the U.K. Results will inform protocol design of Phase 1/2 clinical trial of Company's lead HSV-2 therapeutic vaccine candidate WOBURN, Mass. and OXFORD, England, Aug. 15, 2022 /PRNewswire/ -- Rational Vaccines, a company focused on revolutionizing the treatment and prevention of herpes to eradicate the disease, today announced the ...
-
Creating a Natural Microenvironment for Culturing Islet Cells
Type 1 diabetes is an autoimmune disease that leads to destruction of pancreatic islet cells. For many years, islet transplantation has been the focus of intense investigation as an insulin replacement therapy. Although transplantation immediately achieves insulin independence, the natural ability to continue producing insulin all but disappears 5 years later. There are many problems with ...
-
Genomadix’s European Scientific Advisory Board Comments on TAILOR-PCI Results
Genomadix’s European Scientific Advisory Board Comments on TAILOR-PCI Results *The largest genetics-based clinical trial in cardiology history supported by Genomadix’s Precision Medicine technology * The results of the TAILOR-PCI trial (Tailored Antiplatelet Initiation to Lessen Outcomes Due to Decreased Clopidogrel Response after Percutaneous Coronary Intervention) were recently ...
By Genomadix
-
Genomadix’s Legionella Test used by CDC for Legionnaires’ Outbreak
The CDC chose Genomadix Bioscience, an Ottawa-based biotechnology company, to assist with a Legionnaires’ outbreak in Chesterfield, VA. The Virginia Department of Health (VDH) identified an increase in Legionnaires’ disease cases in Chesterfield County and requested assistance from the Centers for Disease Control and Prevention (CDC). During the investigation, the CDC Pneumonia ...
By Genomadix
-
Novel String-Shaped Subcutaneous ICD Proves Effective in Patients
May 16, 2017 – A new study examines the effectiveness of the implantable subcutaneous string defibrillator (ISSD), a flexible, string-shaped and first-ever rechargeable implantable cardioverter-defibrillator (ICD). This is the first-in-man study to report on the feasibility of the innovative device and was presented today at Heart Rhythm 2017, the Heart Rhythm Society’s 38th Annual ...
By NewPace Ltd.
-
RVx201 Herpes Vaccine
RVx201 Herpes Vaccine Description 2022 RVx201 is a first-in-human herpes simplex virus type 2 (HSV-2) live-attenuated therapeutic vaccine modified to be interferon sensitive that destroys the ability of the virus to inhibit immune responses. Produced by Rational Vaccines, Inc., the technology is based on the pioneering research of the late Dr. William Halford, who dedicated over 25 years to ...
-
Treos Bio Announces the Publication of Preclinical Data in Frontiers in Genetics Showing its COVID-19 Peptide Vaccine Mimics the Diversity of T Cell Immunity Produced by Natural SARS-CoV-2 Infection
LONDON, June 28, 2021 (GLOBE NEWSWIRE) – Treos Bio Limited (“Treos”), a clinical stage biotechnology company using data science and proprietary biomarkers to develop precision off-the-shelf and personalized peptide cancer immunotherapies, today announced the publication of a peer-reviewed article titled “A Peptide Vaccine Candidate Tailored to Individuals’ Genetics ...
-
Ancora Heart Announces Positive Safety and Efficacy Data from Study of First-of-Its-Kind Investigational Heart Failure Therapy
Interim study results from systolic heart failure patients treated with percutaneous therapy designed to improve left ventricular function presented at TCT 2019 Santa Clara, Calif.–September 25, 2019–Ancora Heart, Inc., a company developing a novel therapy to address heart failure, today announced results from an interim analysis of heart failure patients treated in the CorCinch FMR ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you